miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.

PED/PEA-15 (PED) is a death effector domain family member of 15 kDa with a broad antiapoptotic function found overexpressed in a number of different human tumors, including lung cancer. To date, the mechanisms that regulate PED expression are unknown. Therefore, we address this point by the identification of microRNAs that in non-small cell lung cancer (NSCLC) modulate PED levels. In this work, we identify miR-212 as a negative regulator of PED expression. We also show that ectopic expression of this miR increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death in NSCLC cells. In contrast, inhibition of endogenous miR-212 by use of antago-miR results in increase of PED protein expression and resistance to TRAIL treatment. Besides, in NSCLC, we show both in vitro and in vivo that PED and miR-212 expressions are inversely correlated, that is, PED is upregulated and miR-212 is rarely expressed. In conclusion, these findings suggest that miR-212 should be considered as a tumor suppressor because it negatively regulates the antiapoptotic protein PED and regulates TRAIL sensitivity.

[1]  George A. Calin,et al.  MicroRNA-Cancer Connection: The Beginning of a New Tale , 2008 .

[2]  T. Brunner,et al.  miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. , 2009, Cancer research.

[3]  Y. Yatabe,et al.  Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer , 2003, Oncogene.

[4]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[5]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[6]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[7]  Gerolama Condorelli,et al.  PED mediates AKT-dependent chemoresistance in human breast cancer cells. , 2005, Cancer research.

[8]  Feng Bing,et al.  Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1) , 2009, Journal of cellular and molecular medicine.

[9]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[10]  Y. Yatabe,et al.  Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.

[11]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[12]  G. Romano,et al.  Selective inhibition of PED protein expression sensitizes B‐cell chronic lymphocytic leukaemia cells to TRAIL‐induced apoptosis , 2007, International journal of cancer.

[13]  W. Travis.  Pathology of lung cancer. , 2002, Clinics in chest medicine.

[14]  Thomas D. Schmittgen,et al.  In situ detection of mature microRNAs by labeled extension on ultramer templates. , 2009, BioTechniques.

[15]  M. Acunzo,et al.  PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer , 2008, Journal of cellular and molecular medicine.

[16]  F. Beguinot,et al.  Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells* , 2002, The Journal of Biological Chemistry.

[17]  M. Gleave,et al.  PTEN Loss Promotes Mitochondrially Dependent Type II Fas-Induced Apoptosis via PEA-15 , 2008, Molecular and Cellular Biology.

[18]  C. Croce,et al.  MicroRNAs as regulators of death receptors signaling , 2010, Cell Death and Differentiation.

[19]  C. Croce,et al.  MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer , 2008, Oncogene.

[20]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.

[21]  Isabelle Callebaut,et al.  The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes. , 2003, Biochemical pharmacology.

[22]  T. Tuschl,et al.  Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.

[23]  Tasneem Motiwala,et al.  Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer , 2008, Journal of Biological Chemistry.

[24]  G. Condorelli,et al.  PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis , 1999, Oncogene.

[25]  Fabrizio Galimberti,et al.  Uncovering Growth-Suppressive MicroRNAs in Lung Cancer , 2009, Clinical Cancer Research.

[26]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[27]  J. Glowinski,et al.  Knock-Out of the Neural Death Effector Domain Protein PEA-15 Demonstrates That Its Expression Protects Astrocytes from TNFα-Induced Apoptosis , 1999, The Journal of Neuroscience.

[28]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[29]  William H Press,et al.  Human microRNAs target a functionally distinct population of genes with AT-rich 3′ UTRs , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Croce,et al.  The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[32]  F. Andreozzi,et al.  PED/PEA‐15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus , 1998, The EMBO journal.

[33]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.